Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
6 Months : From May 2019 to Nov 2019
By Stephen Nakrosis
Shares of pharmaceutical company Lexicon Pharmaceuticals, Inc. (LXRX) are falling in Friday's after-hours market, after the company said it received notice that Sanofi wanted to terminate an alliance around the diabetes treatment Zynquista.
At 5:30 p.m. ET, Lexicon shares had lost 47.98% to trade at $2.96 per share. Over 250,000 shares traded after-hours. The company's shares finished the day's regular trading session with a 1.43% gain, to close at $5.69.
Lexicon said it told Sanofi it considers the "notice invalid and Sanofi to be in breach of contract."
--Write to Stephen Nakrosis at email@example.com
(END) Dow Jones Newswires
July 26, 2019 17:47 ET (21:47 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.